Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
Vaccines
Influenza Vaccine Coverage Suboptimal for Medicare Beneficiaries
Only half of Medicare beneficiaries aged 19 years and older are vaccinated for influenza, according to a study published online.
CDC Urges Flu Shots as Survey Shows Half of Americans Do Not Plan on It
Nearly half of U.S. adults are not likely to get a flu shot this season, which has prompted federal health officials to urge all Americans to get the flu vaccines.
COVID-19 Vaccines
Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
Safety, Tolerability, Immunogenicity of the Novel Pneumococcal Conjugate Vaccine V114 in Patients at Risk for Pneumococcal Disease
Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.
FDA Grants Fast Track Status to mRNA Respiratory Syncytial Virus Vaccine Candidate
mRNA-1345 is a vaccine candidate against RSV that utilizes the same lipid nanoparticle as Moderna’s authorized COVID-19 vaccine.
Clinical Practice Guidelines: Pulmonary Manifestations in Sjögren Syndrome
Because up to 65% of patients with asymptomatic Sjögren’s syndrome will have abnormal pulmonary imaging, pulmonologists can play a significant role in the diagnosis of Sjögren’s syndrome.
No Detectable Association Between mRNA COVID-19 Vaccines and Facial Paralysis
While several cases of facial paralysis were observed during the phase 3 clinical trials of the mRNA COVID-19 vaccine, a causal relationship could not be established. With the US Food and Drug Administration recommending monitoring of vaccine recipients, the researchers looked at a disproportionality analysis using the WHO’s pharmacovigilance database, VigiBase.
Updated Recommendations on the Use of Anthrax Vaccine in the United States
The CDC’s Prevention’s Advisory Committee on Immunization Practices updated recommendations regarding the use of anthrax vaccine in the US.
No Association Between Influenza Severity and Pediatric Vaccination Rate
Vaccine effectiveness and severity of current and prior seasons of influenza have demonstrated no association with vaccination rate in children, according to a study published in JAMA Pediatrics. Compared with other pediatric and adolescent vaccines, the influenza vaccination rate remains low in children. Although many reasons may affect whether a child is vaccinated, the extent…
- Loading...
Loading...
Next post in Influenza
Loading... 
Loading...